ReviewFoods (Basel, Switzerland)2026
Recent Trends and Developments to Valorize Sheep and Goat Cheese Whey for Small and Medium-Size Enterprises.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioactive Substances in Sheep's Milk and Related Products as Components of Functional Foods.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Sheep and goat milk are mainly used for cheese manufacture in small livestock farms, giving rise to a large volume of whey. Sheep and goat cheese whey possess excellent and specific functional and nutritional characteristics. The valorization of these valuable by-products through physicochemical or biotechnological processes compatible with artisanal production are important in terms of sustainability, i.e., economic, social, and environmental impacts. The main challenges for whey processing in small and medium-size enterprises (SMEs) are the lack of equipment, construction and information as well as the small amounts of cheese whey generated from these plants. Membrane technology can be convenient to produce valuable by-products for small dairy plants in the presence of enough investment cost and whey amount. Biotechnological treatments covering anaerobic digestion systems and fermentation processes are advantageous for SMEs over physicochemical methods on investment cost. In these processes, efficient microorganisms are able to produce high-value natural products, biofuels, and biopolymers. Anaerobic digestion is a suitable method for goat and sheep cheese whey valorization in SMEs due to the small volumes. Additionally, bioconversion into fermented beverages is a good choice for cheese whey valorization in SMEs because of its low operational and equipment cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.